skip to content

Centre for Law, Medicine and Life Sciences

Faculty of Law
 
Anderson

Ms Jennifer Anderson

Jennifer's current research explores questions of liability arising from the use of artificial intelligence in health care. In particular, the project will examine the applicability of the products liability and negligence regimes, as well as other legal frameworks. Jennifer's interests and previous research span a wide array of topics in private law, public law, and legal theory.

Fistein

Dr Elizabeth Fistein- Speciality Director in Ethics and Law, University of Cambridge School of Clinical Medicine

Since 2008, Elizabeth has been running the Ethics and Law component of the Clinical Course, one of the vertical themes that integrate the three stages of the course. She has recently also taken on the role of co-ordinating the Professional Skills curricula within the Clinical Course.

Elizabeth's research interests include legal issues connected to consent to treatment and mental capacity; Empirical Ethics in Psychiatry; Medical education (particularly ethics and professionalism education.

Dr Zoë Fritz - Wellcome Fellow in Society and Ethics, and Consultant Physician in Acute Medicine, Addenbrooke's Hospital

Zoë Fritz is a Wellcome fellow in Society and Ethics, and a Consultant Physician in Acute medicine at Addenbrooke’s Hospital.  Her research is focused on identifying areas of clinical practice that raise ethical questions and applying rigorous empirical and ethical analysis to explore the issues and find effective solutions. Her work is at the interface between medicine, the humanities and law.

Her current work focuses on considering the legal, ethical and empirical consequences of communicating uncertainty in diagnosis: she is collaborating with colleagues in the LML to investigate what constitutes material non-disclosure in the context of forming, communicating and recording a differential diagnosis.

Ms Annie Mackley

Annie provides research and administrative assistance to members of LML across a range of subject areas, most recently on LML's joint project on differential diagnosis with THIS Institute. Annie's research interests include the intersection between tort law and medicine, public health, and emerging technologies in the life sciences. She is currently undertaking a pupilage with Crown Office Chambers.

Dr John Liddicoat

John is broadly interested in the development and use of new technology as it has the ability to: drive economies forward, increase public welfare and resolve important social problems. Much of his research focuses on the ability of patent law to meet its welfare-enhancing goal of accelerating the creation of new technology. In biotechnology and life-sciences — special interests of his — this focus is particularly important, but it is also complicated; although patents can operate as incentives, they have numerous trade-offs. Smart innovation policy requires meticulous, transnational doctrinal research and robust empirical data. As a lawyer with scientific training, John strives to deliver both and have developed numerous new methods using novel data. His research has been funded by the Wellcome Trust, the Philomathia Foundation, and Cancer Research UK, amongst others.

Prof. Timo Minssen

Timo Minssen is Professor of Law at the University of Copenhagen and the Founder and Managing Director of the Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research and advisory practice concentrates on a plethora of legal and ethical issues emerging in the lifecycle of relevant products and processes - from the regulation of responsible research and incentives for innovation to sustainable drug development, technology transfer and commercialization. 

He collaborates with LML colleagues on a variety of issues relating to Intellectual Property, Competition, Data Protection & Regulatory Law within the health and life sciences. Special emphasis is placed on investigating selected challenges and opportunities posed by AMR, artificial intelligence, quantum technology and new platform technologies